Perseus Proteomics Inc. provided earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of JPY 77 million, operating loss of JPY 703 million, loss of JPY 854 million or JPY 72.62 per basic share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
327 JPY | +1.87% | +6.51% | -47.09% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.09% | 2.54Cr | |
+0.20% | 9.13TCr | |
-2.37% | 3.82TCr | |
+71.42% | 2.67TCr | |
-12.31% | 1.59TCr | |
-4.54% | 1.34TCr | |
-10.83% | 1.18TCr | |
+180.20% | 1.09TCr | |
-48.60% | 1.03TCr | |
+1.42% | 868.79Cr |
- Stock Market
- Equities
- 4882 Stock
- News Perseus Proteomics Inc.
- Perseus Proteomics Inc. Provides Earnings Guidance for the Year Ending March 31, 2023